Last updated: 11 March 2024 at 8:42pm EST

Dr. Suresh K. Durgam M.D. Net Worth




The estimated Net Worth of Suresh K. Durgam is at least $5.51 Million dollars as of 7 March 2024. Dr Durgam owns over 10,162 units of Intra-Cellular Therapies Inc stock worth over $1,479,680 and over the last 4 years he sold ITCI stock worth over $3,302,822. In addition, he makes $730,360 as Sr. VP & Chief Medical Officer at Intra-Cellular Therapies Inc.

Dr D ITCI stock SEC Form 4 insiders trading

Dr has made over 17 trades of the Intra-Cellular Therapies Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 10,162 units of ITCI stock worth $672,826 on 7 March 2024.

The largest trade he's ever made was exercising 62,282 units of Intra-Cellular Therapies Inc stock on 2 January 2024 worth over $1,237,543. On average, Dr trades about 10,067 units every 55 days since 2021. As of 7 March 2024 he still owns at least 19,803 units of Intra-Cellular Therapies Inc stock.

You can see the complete history of Dr Durgam stock trades at the bottom of the page.





Dr. Suresh K. Durgam M.D. biography

Dr. Suresh K. Durgam M.D. is the Sr. VP & Chief Medical Officer at Intra-Cellular Therapies Inc.

What is the salary of Dr D?

As the Sr. VP & Chief Medical Officer of Intra-Cellular Therapies Inc, the total compensation of Dr D at Intra-Cellular Therapies Inc is $730,360. There are 9 executives at Intra-Cellular Therapies Inc getting paid more, with Sharon Mates having the highest compensation of $4,724,560.



How old is Dr D?

Dr D is 52, he's been the Sr. VP & Chief Medical Officer of Intra-Cellular Therapies Inc since . There are 13 older and 3 younger executives at Intra-Cellular Therapies Inc. The oldest executive at Intra-Cellular Therapies Inc is Richard Lerner, 81, who is the Independent Director.

What's Dr D's mailing address?

Suresh's mailing address filed with the SEC is C/O INTRA-CELLULAR THERAPIES, INC., 430 EAST 29TH STREET, NEW YORK, NY, 10016.

Insiders trading at Intra-Cellular Therapies Inc

Over the last 11 years, insiders at Intra-Cellular Therapies Inc have traded over $77,703,646 worth of Intra-Cellular Therapies Inc stock and bought 3,068,522 units worth $52,322,638 . The most active insiders traders include Rory B Riggs, Joel S Marcus, and Christopher D Alafi. On average, Intra-Cellular Therapies Inc executives and independent directors trade stock every 17 days with the average trade being worth of $2,787,280. The most recent stock trade was executed by Sharon Mates on 29 August 2024, trading 70,000 units of ITCI stock currently worth $891,100.



What does Intra-Cellular Therapies Inc do?

intra-cellular therapies is a company based out of 3960 broadway, new york, new york, united states.



What does Intra-Cellular Therapies Inc's logo look like?

Intra-Cellular Therapies Inc logo

Complete history of Dr Durgam stock trades at Intra-Cellular Therapies Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
7 Mar 2024 Suresh K. Durgam
EVP and Chief Medical Officer
Sale 10,162 $66.21 $672,826
7 Mar 2024
19,803
6 Mar 2024 Suresh K. Durgam
EVP and Chief Medical Officer
Option 13,132 $66.03 $867,106
6 Mar 2024
22,620
23 Feb 2024 Suresh K. Durgam
EVP and Chief Medical Officer
Option 7,907 $70.16 $554,755
23 Feb 2024
13,600
1 Feb 2024 Suresh K. Durgam
EVP and Chief Medical Officer
Sale 6,167 $67.19 $414,361
1 Feb 2024
5,693
2 Jan 2024 Suresh K. Durgam
EVP and Chief Medical Officer
Option 62,282 $19.87 $1,237,543
2 Jan 2024
62,282
13 Dec 2023 Suresh K. Durgam
EVP and Chief Medical Officer
Sale 21,262 $65.00 $1,382,030
13 Dec 2023
0
17 Jul 2023 Suresh K. Durgam
EVP and Chief Medical Officer
Sale 1,842 $65.00 $119,730
17 Jul 2023
21,262
10 Mar 2023 Suresh K. Durgam
EVP and Chief Medical Officer
Option 7,344 $44.00 $323,136
10 Mar 2023
30,448
23 Feb 2023 Suresh K. Durgam
EVP and Chief Medical Officer
Option 7,906 $47.65 $376,721
23 Feb 2023
31,010
18 Feb 2023 Suresh K. Durgam
EVP and Chief Medical Officer
Option 8,354 $50.01 $417,784
18 Feb 2023
31,458
2 Mar 2022 Suresh K. Durgam
EVP and Chief Medical Officer
Sale 8,037 $56.28 $452,322
2 Mar 2022
23,104
23 Feb 2022 Suresh K. Durgam
EVP and Chief Medical Officer
Option 7,906 $53.05 $419,413
23 Feb 2022
35,187
18 Feb 2022 Suresh K. Durgam
EVP and Chief Medical Officer
Option 8,354 $56.63 $473,087
18 Feb 2022
31,458
18 Jan 2022 Suresh K. Durgam
EVP and Chief Medical Officer
Sale 6,223 $42.03 $261,553
18 Jan 2022
23,104
8 Jan 2022 Suresh K. Durgam
EVP and Chief Medical Officer
Option 13,093 $43.03 $563,392
8 Jan 2022
36,197
18 Feb 2021 Suresh K. Durgam
EVP and Chief Medical Officer
Option 8,354 $39.02 $325,973
18 Feb 2021
25,838
8 Jan 2021 Suresh K. Durgam
EVP and Chief Medical Officer
Option 13,092 $32.95 $431,381
8 Jan 2021
21,851


Intra-Cellular Therapies Inc executives and stock owners

Intra-Cellular Therapies Inc executives and other stock owners filed with the SEC include: